Ciprofloxacin; Dexamethasone is Used for treating ear infections. It was first introduced by Sandoz Inc in its drug Ciprodex on Jul 18, 2003. 5 different companies have introduced drugs containing Ciprofloxacin; Dexamethasone.

Ciprofloxacin; Dexamethasone Patents

Given below is the list of patents protecting Ciprofloxacin; Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Ciprodex	US8846650	Method of treating middle ear infections	Jun 04, 2025 (Expired)	Sandoz
Ciprodex	US9149486	Method of treating middle ear infections	Sep 13, 2022 (Expired)	Sandoz
Ciprodex	US9345714	Method of treating middle ear infections	Sep 13, 2022 (Expired)	Sandoz
Ciprodex	US9402805	Method of treating middle ear infections	Sep 13, 2022 (Expired)	Sandoz
Ciprodex	US6284804	Topical suspension formulations containing ciprofloxacin and dexamethasone	Aug 10, 2020 (Expired)	Sandoz
Ciprodex	US6359016	Topical suspension formulations containing ciprofloxacin and dexamethasone	Aug 10, 2020 (Expired)	Sandoz

Add above patents to watchlist

Ciprofloxacin; Dexamethasone's Family Patents

Full family tree

Ciprofloxacin; Dexamethasone Generic API Manufacturers

Several generic applications have been filed for Ciprofloxacin; Dexamethasone. The first generic version for Ciprofloxacin; Dexamethasone was by Dr Reddys Laboratories Ltd and was approved on Aug 10, 2020. And the latest generic version is by Amneal Eu Ltd and was approved on Mar 22, 2024.

Given below is the list of companies who have filed for Ciprofloxacin; Dexamethasone generic, along with the locations of their manufacturing plants worldwide.